The Fund invested in BioVercys 32,6M CHF = 35M UD$ and got perhaps 10%-15% (?) of the company. Today the market cap of ATH was US$16,38M, much less than it has cash and also much less than what the investment by the Fund was to get 10-15 % (?) of BioVercys.
I do not think the experts of the Fund made any big mistake when they evaluated the value of that company. I would expect the corresponding valuation when and if the Fund evaluates PBT2 and ATH as a possible investments.
- Forums
- ASX - By Stock
- ATH
- Comparison between MC and the investment of the Fund
Comparison between MC and the investment of the Fund
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.98M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
58 | 67819949 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 37853590 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
58 | 67819949 | 0.004 |
52 | 48485564 | 0.003 |
18 | 40599402 | 0.002 |
14 | 93470101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 37853590 | 23 |
0.006 | 33939757 | 15 |
0.007 | 15230649 | 14 |
0.008 | 14174718 | 13 |
0.009 | 6000000 | 5 |
Last trade - 10.42am 03/07/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online